Vimarsana
Biggest News Aggregation in the World

Par Prevailed News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Par Prevailed. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Par Prevailed Today - Breaking & Trending Today

Par Pharm., Inc. v. Hospira, Inc. | Robins Kaplan LLP - Vimarsana News

Par Pharm., Inc. v. Hospira, Inc. | Robins Kaplan LLP

Adrenalin® (epinephrine injection) Case Name: Par Pharm., Inc. v. Hospira, Inc., No. 2020-1273, 2020 WL 6846347 (Fed. Cir. Nov. 23, 2020) (Circuit Judges Dyk, Taranto, and Stoll presiding; Opinion by Taranto, J.) (Appeal from D. Del., Bataillon, J.) Drug Product and Patent(s)-in-Suit: Adrenalin® (epinephrine injection); U.S. Patents Nos. 9,119,876 (“the ’876 patent”) and 9,295,657 (“the ’657 patent”) Nature of Case and Issue(s) Presented: In 2017, Hospira filed an ANDA seeking permission to market a generic version of Par’s Adrenalin® epinephrine injection. Par sued Hospira ...